On the edge: targeting Toll-like receptor 2 in ischemia/reperfusion injury

Circ Cardiovasc Interv. 2012 Apr;5(2):146-9. doi: 10.1161/CIRCINTERVENTIONS.112.968495.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Animals
  • Antibodies, Monoclonal, Humanized / administration & dosage*
  • Female
  • Heart / drug effects*
  • Humans
  • Myocardial Infarction / drug therapy*
  • Myocardium / metabolism*
  • Reperfusion Injury / prevention & control*
  • Toll-Like Receptor 2 / immunology*

Substances

  • Antibodies, Monoclonal, Humanized
  • Toll-Like Receptor 2